Codadose

CodaDose is a specialty pharmaceutical company dedicated to improving the safety and accuracy of pediatric drug administration. Based in Flowery Branch, Georgia, the company utilizes its proprietary CodaDose system, which integrates customized liquid formulations with specialized delivery components like flow restrictors and precision oral dispensers to prevent dosing errors and accidental ingestion. Their lead product, Vyscoxa (celecoxib) oral suspension, received FDA approval in 2025 for the treatment of juvenile rheumatoid arthritis in patients aged 2 years and older. The company also markets the Zodryl line of pediatric cough medications, all designed to minimize the risk of adverse drug events in young children. CodaDose operates with a focus on "Dosing Done Right" to address critical unmet needs in the pediatric healthcare market.